DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1‐Mediated NRF2 Ubiquitination
Abstract Chemoresistance is the main obstacle in osteosarcoma (OS) treatment; however, the underlying mechanism remains unclear. In this study, it is discovered that DDRGK domain‐containing protein 1 (DDRGK1) plays a fundamental role in chemoresistance induced in OS. Bioinformatic and tissue analyse...
Saved in:
| Main Authors: | Xin Wang, Tangjun Zhou, Xiao Yang, Xiankun Cao, Gu Jin, Pu Zhang, Jiadong Guo, Kewei Rong, Baixing Li, Yibin Hu, Kexin Liu, Peixiang Ma, An Qin, Jie Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-05-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202204438 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and validation of a predictive score for chemoresistance in high-grade osteosarcoma at baseline
by: Thanat Kanthawang, et al.
Published: (2025-07-01) -
Extracellular matrix production and oxygen diffusion regulate chemotherapeutic response in osteosarcoma spheroids
by: Isabel S. Sagheb, et al.
Published: (2024-09-01) -
USP51/GRP78/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells
by: Yang Ou, et al.
Published: (2025-05-01) -
Treatment outcomes for adult patients with localized osteosarcoma treated with chemotherapy without methotrexate at a public hospital in Brazil
by: Marilia Polo Minguete-e-Silva, et al.
Published: (2021-10-01) -
A Dual Approach with Organoid and CRISPR Screening Reveals ERCC6 as a Determinant of Cisplatin Resistance in Osteosarcoma
by: Ruiling Xu, et al.
Published: (2025-07-01)